Spark Coverage Cup

Media relations is at the heart of a successful campaign and our team take great pride in beating their colleagues to win the weekly Spark Coverage Cup vote.

The winning piece of coverage isn’t just about circulation or credibility. A great business national or broadcast piece doesn’t always beat trade coverage – outcomes are key. How effectively was the client’s message communicated? What was the engagement like? Did it result in leads?

While earned coverage is now only part of what we do, the impact of what we deliver is often why clients choose to work with us in the first place. It’s why 80% of our clients come through referral and why some of our clients have stayed with us for over ten years.

Below are some of our previous highlights:

Coverage Cup 23/08/2023

Welcome back to another Coverage Cup round-up. Let’s kick off with some quality coverage for Quadient, reaping the rewards of our group effort to pitch journalists about new Consumer Duty legislation. The team’s tactic of sharing comment weeks ahead of the new rules coming into play was rewarded with coverage in BBC News Online. And a successful letter-to-the-editor from Quadient was published in The Financial Times, drawing a link between the rules and the difference between US and UK banking.

We’ve also had some interesting interviews in recent weeks. The CIISec team were in the thick of the action when news emerged of a hack on The Electoral Commission, arranging an interview for CIISec’s CEO on Sky News while the story was unfolding. Meanwhile, our Imperva team set up some briefings for the CTO’s visit to the UK and Ireland. Having built an interesting pitch around the risk that could be posed by “FraudGPT”, they set up an interview with City AM and capitalised on his subsequent trip to Dublin with a spot on The Irish Tech News Podcast.

We also achieved more national coverage for three clients in The Times / Raconteur Cloud for Business supplement. Our Harness and Venafi teams outlined challenges that cloudflation poses for FinOps. Meanwhile, Cloudera’s insights on how to decide whether to host AI workloads in shared public cloud or on-premises environments appeared in a feature on cloud costs and generative AI.

And finally, the life sciences team have been generating coverage in core trade titles Medical Device Network and MedTech Insight with the latest product news from PacBio on its short read sequencing platform. This was followed by a piece in Technology Networks covering PacBio’s latest research collaboration on rare disease research, and PM Live published a new bylined article from PacBio giving a deep-dive on the “silent pandemic” – antimicrobial resistance.

Check out some of this coverage by clicking the links on the right.